Literature DB >> 19150340

(-)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB.

Ru-Wei Lin1, Chung-Hwan Chen, Yan-Hsiung Wang, Mei-Ling Ho, Shao-Hung Hung, Ih-Sheng Chen, Gwo-Jaw Wang.   

Abstract

People who regularly drink tea have been found to have a higher bone mineral density (BMD) and to be at less risk of hip fractures than those who do not drink it. Green tea catechins such as (-)-epigallocatechin gallate (EGCG) have been reported to increase osteogenic functioning in mesenchymal stem cells. However, its effect on osteoclastogenesis remains unclear. In this study, we investigated the effect of EGCG on RANKL-activation osteoclastogenesis and NF-kappaB in RAW 264.7, a murine preosteoclast cell line. EGCG (10-100 microM) significantly suppressed the RANKL-induced differentiation of osteoclasts and the formation of pits in murine RAW 264.7 cells and bone marrow macrophages (BMMs). EGCG appeared to target osteoclastic differentiation at an early stage but had no cytotoxic effect on osteoclast precursors. In addition, it significantly inhibited RANKL-induced NF-kappaB transcriptional activity and nuclear translocation. We conclude that EGCG inhibits osteoclastogenesis through its activation of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150340     DOI: 10.1016/j.bbrc.2009.01.007

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  Tea and bone health: steps forward in translational nutrition.

Authors:  Chwan-Li Shen; Ming-Chien Chyu; Jia-Sheng Wang
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

Review 2.  Targeting of histamine producing cells by EGCG: a green dart against inflammation?

Authors:  Esther Melgarejo; Miguel Angel Medina; Francisca Sánchez-Jiménez; José Luis Urdiales
Journal:  J Physiol Biochem       Date:  2010-07-22       Impact factor: 4.158

3.  Effect of (-)-epigallocatechin-3-gallate in preventing bone loss in ovariectomized rats and possible mechanisms.

Authors:  Dawei Song; Minfeng Gan; Jun Zou; Xuesong Zhu; Qin Shi; Huan Zhao; Zongping Luo; Wen Zhang; Shiyan Li; Junjie Niu; Hai Zhu; Hao Chen; Chenxi Yuan; Xiaochen Liu; Huilin Yang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 4.  Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].

Authors:  Rashmi Singh; Nahid Akhtar; Tariq M Haqqi
Journal:  Life Sci       Date:  2010-05-10       Impact factor: 5.037

Review 5.  Green tea and bone health: Evidence from laboratory studies.

Authors:  Chwan-Li Shen; James K Yeh; Jay J Cao; Ming-Chien Chyu; Jia-Sheng Wang
Journal:  Pharmacol Res       Date:  2011-04-05       Impact factor: 7.658

Review 6.  Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise.

Authors:  Salahuddin Ahmed
Journal:  Arthritis Res Ther       Date:  2010-04-28       Impact factor: 5.156

Review 7.  Green tea and bone metabolism.

Authors:  Chwan-Li Shen; James K Yeh; Jay J Cao; Jia-Sheng Wang
Journal:  Nutr Res       Date:  2009-07       Impact factor: 3.315

8.  (-)-Epicatechin gallate (ECG) stimulates osteoblast differentiation via Runt-related transcription factor 2 (RUNX2) and transcriptional coactivator with PDZ-binding motif (TAZ)-mediated transcriptional activation.

Authors:  Mi Ran Byun; Mi Kyung Sung; A Rum Kim; Cham Han Lee; Eun Jung Jang; Mi Gyeong Jeong; Minsoo Noh; Eun Sook Hwang; Jeong-Ho Hong
Journal:  J Biol Chem       Date:  2014-02-10       Impact factor: 5.157

9.  Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats.

Authors:  C-L Shen; J K Yeh; J J Cao; O L Tatum; R Y Dagda; J-S Wang
Journal:  Osteoporos Int       Date:  2010-01-13       Impact factor: 4.507

10.  Different differentiation of stroma cells from patients with osteonecrosis: a pilot study.

Authors:  Ching-Hua Yeh; Je-Ken Chang; Mei-Ling Ho; Chung-Hwan Chen; Gwo-Jaw Wang
Journal:  Clin Orthop Relat Res       Date:  2009-03-28       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.